History | Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Declaration of interests

Register of interests (PDF 1.12 MB)

Published:

29 October 2021

Guidance published

Equality impact assessment 4 (PDF 134 KB)

Published:

29 October 2021
Guideline appendix - acknowledgements (PDF 208 KB)

Published:

29 October 2021
Committee member list (PDF 136 KB)

Published:

29 October 2021
Consultation comments and responses - 1 of 2 (PDF 18.16 MB)

Published:

29 October 2021
Consultation comments and responses - 2 of 2 (PDF 15.43 MB)

Published:

21 December 2021

Stakeholder list updated

Stakeholder list (PDF 184 KB)

Published:

28 October 2021

Stakeholder workshop

Workshop notes - ME/CFS roundtable discussion points (PDF 90 KB)

Published:

13 October 2021
Workshop notes - ME/CFS roundtable agenda (PDF 158 KB)

Published:

13 October 2021
Minutes - ME/CFS roundtable minutes (PDF 185 KB)

Published:

29 October 2021
Workshop notes - ME/CFS roundtable presentation (PDF 878 KB)

Published:

29 October 2021

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 896 KB)

Published:

10 November 2020
Supporting documentation - Children and Young people (PDF 1016 KB)

Published:

10 November 2020
Supporting documentation - People with severe ME/ CFS (PDF 1.18 MB)

Published:

10 November 2020
Supporting documentation - Expert testimonies (PDF 496 KB)

Published:

10 November 2020
Supporting documentation - Methods chapter (PDF 792 KB)

Published:

10 November 2020
Evidence review A - Information for people with ME/ CFS (PDF 1.88 MB)

Published:

10 November 2020
Evidence review B - Information for health and social care professionals (PDF 2.62 MB)

Published:

10 November 2020
Evidence review C - Access to care (PDF 3.27 MB)

Published:

10 November 2020
Evidence review D - Diagnosis (PDF 2.14 MB)

Published:

10 November 2020
Evidence review E - Strategies pre-diagnosis (PDF 1.82 MB)

Published:

10 November 2020
Evidence review F - Pharmacological management (PDF 4.45 MB)

Published:

10 November 2020
Evidence review G - Non pharmacological management (PDF 4.14 MB)

Published:

10 November 2020
Evidence review H – Non pharma management appendices (PDF 8.26 MB)

Published:

10 November 2020
Evidence review I – Multidisciplinary care (PDF 1.37 MB)

Published:

10 November 2020
Evidence review J - Review of care (PDF 1.66 MB)

Published:

10 November 2020
Equality impact assessment 3 (PDF 111 KB)

Published:

10 November 2020
Comments form (MSWord 37 KB)

Published:

10 November 2020
Supporting documentation (PDF 1.19 MB)

Published:

10 November 2020

Pre-consultation documents released

Economic plan (PDF 18 KB)

Published:

10 September 2020
Review questions (PDF 31 KB)

Published:

10 September 2020
Search strategies (PDF 248 KB)

Published:

10 September 2020

Call for evidence

Call for evidence
Call for evidence response form (MSWord 70 KB)

Published:

30 August 2019
Confidentiality form (MSWord 70 KB)

Published:

30 August 2019

Committee meetings

Committee meeting
Minutes GC 1 (PDF 837 KB)

Published:

06 February 2019
Minutes GC 2 (PDF 119 KB)

Published:

29 March 2019
Minutes 3 (PDF 107 KB)

Published:

20 May 2019
Minutes GC4 (PDF 114 KB)

Published:

08 July 2019
Minutes 5 (PDF 111 KB)

Published:

05 September 2019
Minutes 6 (PDF 96 KB)

Published:

06 September 2019
Minutes 7 (PDF 120 KB)

Published:

22 October 2019
Minutes 8 (PDF 145 KB)

Published:

23 October 2019
Minutes 9 (PDF 196 KB)

Published:

10 December 2019
Minutes 10 (PDF 182 KB)

Published:

11 December 2019
Minutes 11 (PDF 186 KB)

Published:

29 January 2020
Minutes 12 (PDF 185 KB)

Published:

30 January 2020
Minutes 13 (PDF 156 KB)

Published:

17 March 2020
Minutes 14 (PDF 217 KB)

Published:

13 July 2020
Minutes 15 (PDF 209 KB)

Published:

20 July 2020
Minutes 16 (PDF 181 KB)

Published:

24 July 2020
Minutes 17 (PDF 175 KB)

Published:

31 July 2020
Minutes 18 (PDF 169 KB)

Published:

07 August 2020
Minutes 19 (PDF 182 KB)

Published:

10 August 2020
Minutes 20 (PDF 170 KB)

Published:

14 August 2020
Minutes 21 (PDF 172 KB)

Published:

01 March 2021
Minutes 22 (PDF 231 KB)

Published:

05 March 2021
Minutes 23 (PDF 219 KB)

Published:

08 March 2021
Minutes 24 (PDF 165 KB)

Published:

15 March 2021
Minutes 25 (PDF 159 KB)

Published:

19 March 2021
Minutes 26 (PDF 162 KB)

Published:

22 March 2021
Minutes 27 (PDF 159 KB)

Published:

19 April 2021
Minutes 28 (PDF 161 KB)

Published:

23 April 2021
Minutes 29 (PDF 162 KB)

Published:

27 April 2021
Minutes 30 (PDF 159 KB)

Published:

29 April 2021

Scope published

Final scope (PDF 169 KB)

Published:

16 October 2018
Equality impact assessment 2 (PDF 240 KB)

Published:

16 October 2018
Consultation comments and responses (PDF 5.12 MB)

Published:

16 October 2018

Draft scope consultation

Draft scope consultation
Equality impact assessment 1 (PDF 229 KB)

Published:

20 June 2018
Comments form (MSWord 63 KB)

Published:

20 June 2018
Draft scope (PDF 307 KB)

Published:

27 June 2018

Scoping workshop

Workshop notes (PDF 384 KB)

Published:

20 June 2018

Review documents

Interim findings Notes from stakeholder engagement workshop on 16 January 2018 (PDF 435 KB)

Published:

24 May 2018